From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
“The idea of having a trusted partner was so important to us leading up to launch.”
Senior Vice President | Finance
We know how much weighs on the minds of pre-commercial pharmaceutical manufacturers. Clinical trials, government agency meetings, regulatory approval…not to mention the lead time required to execute contract strategy, forecast models, channel and distribution strategy and a data strategy to support drug launch goals.
In order to be ready for Day 1, pharma manufacturers need to stand up contracts & pricing, gross-to-net, channel strategies and patient services functions with a constrained budget and few internal resources. A successful drug launch strategy requires orderly launch preparation across critical business functions, who are often working in silos to achieve their respective goals.
Both new and emerging pharma manufacturers can benefit from our launch readiness solutions and achieve a faster, smoother drug commercialization process.
Pre Launch Insights into competitive market baskets for benchmarking
Analogs and data to build consensus forecasts at a line item level
Government Pre-Deal Analysis and Contract Document Creation
Build and execute forecast models and data strategy to support launch goals
Anticipated channel and distribution strategy – Clinic, Retail, Specialty Pharmacy, Specialty Infusion
Reporting infrastructure set for launch to support trade, market access, finance and patient services
Commercialization Strategy & Operational Consulting.
IntegriChain’s ICyte platform and consulting services help solve these launch readiness challenges with a fully-integrated and scalable approach. Unified data offers a single source of truth, with pre-built data integration to all third party logistic providers (3PLs), Specialty distributor (SD), FLOW, Copay, SP and HUB providers. We offer market insights and data to drive top down and bottoms up commercial and financial plans.
Successful pharmaceutical manufacturers create a sound drug launch strategy by choosing a partner that can outline and evolve strategy to market access execution, while maintaining agility to pivot along the path to commercialization.
Proven Commercial, Government and Compliance, and Gross-to-Net Roadmap to LaunchTM blueprints
Benchmark data for peer contracting and rebating strategies
Establish clear line-of-sight into net-price
Operationalize commercial and government contracting
Timely and Accurate Medicaid and Managed Care Rebates processing
Manage increasing state-level requirements for pricing transparency
Measure Operational Performance Day 1 with actionable data
Experienced SMEs provides consulting and advisors services
Roadmap to Launch Consulting.
A top 10 pharmaceutical manufacturer was preparing to launch a complex oncology combination regimen with two novel agents but was faced with several unique commercial challenges.
Download the Case Study
We asked three market access leaders with significant launch experience across multiple therapeutic categories from companies planning to launch or have launched their first product several questions about their launch journey.
Read the post
